Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MIE for Encopresis in Children with ASD
NCT03197922Phase 3Completed
- Sponsor
- Emory University
- Start
- Oct 2017
- Primary completion
- Nov 2022
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial (3 arms), sponsored by Emory University. Primary endpoint: Percentage of Continent Bowel Movements at Week 8. Started Oct 2017; status: completed.
Beyond the preview
Go deeper on NCT03197922.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03197922.